Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review

Metabolomics

Volumn 11, Issue 4, 2015, Pages 872-894

  Emwas, Abdul Hamid ^a   Luchinat, Claudio ^b   Turano, Paola ^b   Tenori, Leonardo ^c   Roy, Raja ^d   Salek, Reza M ^e,f   Ryan, Danielle ^g   Merzaban, Jasmeen S ^a   Kaddurah Daouk, Rima ^h   Zeri, Ana Carolina ⁱ   Nagana Gowda, G A ^j   Raftery, Daniel ^j   Wang, Yulan ^k   Brennan, Lorraine ^l   Wishart, David S ^m  

^a KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Saudi Arabia)

^b UNIVERSITY OF FLORENCE   (Italy)

^c FiorGen Foundation   (Italy)

^d SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^g CHARLES STURT UNIVERSITY   (Australia)

^h DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ BRAZILIAN CENTER FOR RESEARCH IN ENERGY AND MATERIALS CNPEM   (Brazil)

^j UNIVERSITY OF WASHINGTON   (United States)

^k Wuhan National Laboratory for Optoelectronics   (China)

^l School of Agriculture Food Science   (Ireland)

^m UNIVERSITY OF ALBERTA   (Canada)

more..

Author keywords

Biomarker; Diagnosis; Human diseases; Metabolites profiling; Metabolomics; Metabonomics; NMR; Recommendations; Standardization; Urine

Indexed keywords

DIAGNOSTIC PROCEDURE; DISEASE COURSE; HUMAN; HUMAN URINE METABOLOME; METABOLOME; MICROFLORA; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PH MEASUREMENT; PHYSICAL ACTIVITY; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; STANDARDIZATION; STORAGE; URINALYSIS;

EID: 84931562865     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-014-0746-7     Document Type: Review

References (222)

1. Abbiss, H., Maker, G. L., Gummer, J., Sharman, M. J., Phillips, J. K., Boyce, M., et al. (2012). Development of a non-targeted metabolomics method to investigate urine in a rat model of polycystic kidney disease. Nephrology,17(2), 104–110. doi:10.1111/j.1440-1797.2011.01532.x.
2. Abuhijleh, A. L., Abu Ali, H., & Emwas, A.-H. (2009). Synthesis, spectral and structural characterization of dinuclear rhodium (II) complexes of the anticonvulsant drug valproate with theophylline and caffeine. Journal of Organometallic Chemistry,694(22), 3590–3596. doi:10.1016/j.jorganchem.2009.07.031.
3. Ala-Korpela, M. (2007). Potential role of body fluid H-1 NMR metabonomics as a prognostic and diagnostic tool. Expert Review of Molecular Diagnostics,7(6), 761–773. doi:10.1586/14737159.7.6.761.
4. Alberice, J. V., Amaral, A. F. S., Grace Armitage, E., Antonio Lorente, J., Algaba, F., Carrilho, E., et al. (2013). Searching for urine biomarkers of bladder cancer recurrence using a liquid chromatography–mass spectrometry and capillary electrophoresis–mass spectrometry metabolomics approach. Journal of Chromatography A,1318, 163–170. doi:10.1016/j.chroma.2013.10.002.
5. Allard, E., Backstrom, D., Danielsson, R., Sjobberg, J. R., & Bergquist, J. (2008). Comparing capillary electrophoresis—mass spectrometry fingerprints of urine samples obtained after intake of coffee, tea, or water. Analytical Chemistry,80(23), 8946–8955. doi:10.1021/ac801012y.
6. Al-Talla, Z. A., Akrawi, S. H., & Emwas, A. H. M. (2011a). Solid state NMR and bioequivalence comparison of the pharmacokinetic parameters of two formulations of clindamycin. International Journal of Clinical Pharmacology and Therapeutics,49(7), 469–476. doi:10.5414/cp201478.
7. Al-Talla, Z. A., Akrawi, S. H., Tolley, L. T., Sioud, S. H., Zaater, M. F., & Emwas, A. H. (2011b). Bioequivalence assessment of two formulations of ibuprofen. Drug Design, Development and Therapy,5, 427–433. doi:10.2147/DDDT.S24504.
8. Ardenkjær-Larsen, J. H., Fridlund, B., Gram, A., Hansson, G., Hansson, L., Lerche, M. H., et al. (2003). Increase in signal-to-noise ratio of >10,000 times in liquid-state NMR. Proceedings of the National Academy of Sciences,100(18), 10158–10163.
9. Assfalg, M., Bertini, I., Colangiuli, D., Luchinat, C., Schaefer, H., Schuetz, B., et al. (2008). Evidence of different metabolic phenotypes in humans. Proceedings of the National Academy of Sciences of the United States of America,105(5), 1420–1424. doi:10.1073/pnas.0705685105.
10. Atzori, L., Antonucci, R., Barberini, L., Locci, E., Cesare Marincola, F., Scano, P., et al. (2010). 1H NMR-based metabolic profiling of urine from children with nephrouropathies. Frontiers in Bioscience (Elite Edition),2, 725–732. doi:10.2741/e132.
11. Balog, C. I. A., Meissner, A., Goraler, S., Bladergroen, M. R., Vennervald, B. J., Mayboroda, O. A., et al. (2011). Metabonomic investigation of human Schistosoma mansoni infection. Molecular BioSystems,7(5), 1473–1480. doi:10.1039/c0mb00262c.
12. Barton, R. H., Nicholson, J. K., Elliott, P., & Holmes, E. (2008). High-throughput 1H NMR-based metabolic analysis of human serum and urine for large-scale epidemiological studies: Validation study. International Journal of Epidemiology,37(Suppl 1), i31–i40. doi:10.1093/ije/dym284.
13. Bernini, P., Bertini, I., Calabro, A., la Marca, G., Lami, G., Luchinat, C., et al. (2011a). Are Patients with potential celiac disease really potential? The answer of metabonomics. Journal of Proteome Research,10(2), 714–721. doi:10.1021/pr100896s.
14. Bernini, P., Bertini, I., Luchinat, C., Nepi, S., Saccenti, E., Schaefer, H., et al. (2009). Individual human phenotypes in metabolic space and time. Journal of Proteome Research,8(9), 4264–4271. doi:10.1021/pr900344m.
15. Bernini, P., Bertini, I., Luchinat, C., Nincheri, P., Staderini, S., & Turano, P. (2011b). Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks. Journal of Biomolecular NMR,49(3–4), 231–243. doi:10.1007/s10858-011-9489-1.
16. Bertini, I., Calalbro, A., De Carli, V., Luchinat, C., Nepi, S., Porfirio, B., et al. (2009). The Metabonomic Signature of Celiac Disease. Journal of Proteome Research,8(1), 170–177. doi:10.1021/pr800548z.
17. Bertram, H. C., Hoppe, C., Petersen, B. O., Duus, J. O., Molgaard, C., & Michaelsen, K. F. (2007a). An NMR-based metabonomic investigation on effects of milk and meat protein diets given to 8-year-old boys. British Journal of Nutrition,97(4), 758–763. doi:10.1017/s0007114507450322.
18. Bertram, H. C., Malmendal, A., Petersen, B. O., Madsen, J. C., Pedersen, H., Nielsen, N. C., et al. (2007b). Effect of magnetic field strength on NMR-Based metabonomic human urine data comparative study of 250, 400, 500, and 800 MHz. Analytical Chemistry,79(18), 7110–7115. doi:10.1021/acO70928a.
19. Bertram, H. C., Yde, C. C., Zhang, X., & Kristensen, N. B. (2011). Effect of dietary nitrogen content on the urine metabolite profile of dairy cows assessed by nuclear magnetic resonance (NMR)-based metabolomics. Journal of Agricultural and Food Chemistry,59(23), 12499–12505. doi:10.1021/jf204201f.
20. Blindauer, C. A., Emwas, A. H., Holy, A., Dvorakova, H., Sletten, E., & Sigel, H. (1997). Complex formation of the antiviral 9–2-(phosphonomethoxy)ethyl adenine (PMEA) and of its N1, N3, and N7 deaza derivatives with copper(II) in aqueous solution. Chemistry:A European Journal,3(9), 1526–1536. doi:10.1002/chem.19970030922.
21. Blumberg, R., & Powrie, F. (2012). Microbiota, disease, and back to health: A metastable journey. Science Translational Medicine,4(137), 12. doi:10.1126/scitranslmed.3004184.
22. Bouatra, S., Aziat, F., Mandal, R., Guo, A. C., Wilson, M. R., Knox, C., et al. (2013). The human urine metabolome. PloS One, 8(9). doi:10.1371/journal.pone.0073076.
23. Boudonck, K. J., Mitchell, M. W., Nemet, L., Keresztes, L., Nyska, A., Shinar, D., et al. (2009). Discovery of metabolomics biomarkers for early detection of nephrotoxicity. Toxicologic Pathology,37(3), 280–292. doi:10.1177/0192623309332992.
24. Bubb, W. A. (2003). NMR spectroscopy in the study of carbohydrates: Characterizing the structural complexity. Concepts in Magnetic Resonance Part A,19A(1), 1–19. doi:10.1002/cmr.a.10080.
25. Cai, H.-L., Li, H.-D., Yan, X.-Z., Sun, B., Zhang, Q., Yan, M., et al. (2012). Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naive schizophrenia patients after treatment with risperidone. Journal of Proteome Research,11(8), 4338–4350. doi:10.1021/pr300459d.
26. Calvani, R., Miccheli, A., Capuani, G., Miccheli, A. T., Puccetti, C., Delfini, M., et al. (2010). Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype. International Journal of Obesity,34(6), 1095–1098. doi:10.1038/ijo.2010.44.
27. Cao, H., Dong, J., Cai, C., & Chen, Z. (2008). Investigations on the effects of NMR experimental conditions in human urine and serum metabolic profiles. IEEE,8(3), 2236–2239.
28. Carrola, J., Rocha, C. M., Barros, A. S., Gil, A. M., Goodfellow, B. J., Carreira, I. M., et al. (2011). Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine. Journal of Proteome Research,10(1), 221–230. doi:10.1021/pr100899x.
29. Cascante, M., Boros, L. G., Comin-Anduix, B., de Atauri, P., Centelles, J. J., & Lee, P. W. N. (2002). Metabolic control analysis in drug discovery and disease. Nature Biotechnology,20(3), 243–249.
30. Cathcartrake, W., Porter, R., Whittier, F., Stein, P., Carey, M., & Grantham, J. (1975). Effect of diet on serum accumulation and renal excretion of aryl acids and secretory activity in normal and uremic man. American Journal of Clinical Nutrition,28(10), 1110–1115.
31. Chan, D. C., Watts, G. F., Barrett, P. H. R., & Burke, V. (2003). Waist circumference, waist-to-hip ratio and body mass index as predictors of adipose tissue compartments in men. Qjm-An International Journal of Medicine,96(6), 441–447. doi:10.1093/qjmed/hcg069.
32. Chekmenev, E. Y., Norton, V. A., Weitekamp, D. P., & Bhattacharya, P. (2009). Hyperpolarized 1H NMR employing low γ nucleus for spin polarization storage. Journal of the American Chemical Society,131(9), 3164–3165.
33. Chen, Y.-H., Chen, C.-H., Lin, C.-J., & Chen, C.-C. (2009). Metabonomic study with a high performance liquid chromatography coupling to a triple quadruple mass spectrometer to identify biomarkers from urine of high-fat fed and streptozotocin treated rats. Journal of Food and Drug Analysis,17(1), 28–35.
34. Chen, T., Xie, G., Wang, X., Fan, J., Qui, Y., Zheng, X., et al. (2011). Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Molecular and Cellular Proteomics,10(11), 1. doi:10.1074/mcp.A110.004945.
35. Cho, S.-H., Choi, M. H., Kwon, O. S., Lee, W.-Y., & Chung, B. C. (2009). Metabolic significance of bisphenol A-induced oxidative stress in rat urine measured by liquid chromatography-mass spectrometry. Journal of Applied Toxicology,29(2), 110–117. doi:10.1002/jat.1387.
36. Clayton, T. A., Lindon, J. C., Cloarec, O., Antti, H., Charuel, C., Hanton, G., et al. (2006). Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature,440(7087), 1073–1077. doi:10.1038/nature04648.
37. Clifford, M. N., Copeland, E. L., Bloxsidge, J. P., & Mitchell, L. A. (2000). Hippuric acid as a major excretion product associated with black tea consumption. Xenobiotica,30(3), 317–326.
38. Constantinou, M. A., Papakonstantinou, E., Spraul, M., Sevastiadou, S., Costalos, C., Koupparis, M. A., et al. (2005). H-1 NMR-based metabonomics for the diagnosis of inborn errors of metabolism in urine. Analytica Chimica Acta,542(2), 169–177. doi:10.1016/j.aca.2005.03.059.
39. Cotran, R., Kendrick, M. I., & Kass, E. H. (1960). Role of intestinal bacteria in aromatization of quinic acid in man and guinea pig. Proceedings of the Society for Experimental Biology and Medicine,104(3), 424–426.
40. Culeddu, N., Chessa, M., Porcu, M. C., Fresu, P., Tonolo, G., Virgilio, G., et al. (2012). NMR-based metabolomic study of type 1 diabetes. Metabolomics,8(6), 1162–1169. doi:10.1007/s11306-012-0420-x.
41. Czernichow, S., Kengne, A.-P., Huxley, R. R., Batty, G. D., de Galan, B., Grobbee, D., et al. (2011). Comparison of waist-to-hip ratio and other obesity indices as predictors of cardiovascular disease risk in people with type-2 diabetes: A prospective cohort study from ADVANCE. European Journal of Cardiovascular Prevention and Rehabilitation,18(2), 312–319. doi:10.1097/HJR.0b013e32833c1aa3.
42. Davis, V. W., Schiller, D. E., Eurich, D., & Sawyer, M. B. (2012). Urinary metabolomic signature of esophageal cancer and Barrett’s esophagus. World Journal of Surgical Oncology,10, 12. doi:10.1186/1477-7819-10-271.
43. Dawiskiba, T., Deja, S., Mulak, A., Zabek, A., Jawien, E., Pawelka, D., et al. (2014). Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases. World Journal of Gastroenterology,20(1), 163–174. doi:10.3748/wjg.v20.i1.163.
44. Day, S. E., Kettunen, M. I., Gallagher, F. A., Hu, D. E., Lerche, M., Wolber, J., et al. (2007). Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy. Nature Medicine,13(11), 1382–1387.
45. de Koning, L., Merchant, A. T., Pogue, J., & Anand, S. S. (2007). Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: Meta-regression analysis of prospective studies. European Heart Journal,28(7), 850–856. doi:10.1093/eurheartj/ehm026.
46. Deja, S., Barg, E., Mlynarz, P., Basiak, A., & Willak-Janc, E. (2013). H-1 NMR-based metabolomics studies of urine reveal differences between type 1 diabetic patients with high and low HbAc1 values. Journal of Pharmaceutical and Biomedical Analysis,83, 43–48. doi:10.1016/j.jpba.2013.04.017.
47. Delanghe, J., & Speeckaert, M. (2014). Preanalytical requirements of urinalysis. Biochemia Medica,24(1), 89–104.
48. Di Gangi, I. M., Vrhovsek, U., Pazienza, V., & Mattivi, F. (2014). Analytical metabolomics-based approaches to pancreatic cancer. Trac-Trends in Analytical Chemistry,55, 94–116. doi:10.1016/j.trac.2013.12.006.
49. Diaz, S. O., Barros, A. S., Goodfellow, B. J., Duarte, I. F., Carreira, I. M., Galhano, E., et al. (2013). Following healthy pregnancy by nuclear magnetic resonance (NMR) metabolic profiling of human urine. Journal of Proteome Research,12(2), 969–979. doi:10.1021/pr301022e.
50. Dong, B., Jia, J., Hu, W., Chen, Q., Jiang, C., Pan, J., et al. (2013). Application of H-1 NMR metabonomics in predicting renal function recoverability after the relief of obstructive uropathy in adult patients. Clinical Biochemistry,46(4–5), 346–353. doi:10.1016/j.clinbiochem.2012.11.012.
51. Duarte, I. F., Diaz, S. O., & Gil, A. M. (2014). NMR metabolomics of human blood and urine in disease research. Journal of Pharmaceutical and Biomedical Analysis,93, 17–26. doi:10.1016/j.jpba.2013.09.025.
52. Duarte, I. F., & Gil, A. M. (2012). Metabolic signatures of cancer unveiled by NMR spectroscopy of human biofluids. Progress in Nuclear Magnetic Resonance Spectroscopy,62, 51–74. doi:10.1016/j.pnmrs.2011.11.002.
53. Dumas, M.-E., Barton, R. H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., et al. (2006). Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proceedings of the National Academy of Sciences of the United States of America,103(33), 12511–12516. doi:10.1073/pnas.0601056103.
54. Dunne, C. (2001). Adaptation of bacteria to the intestinal niche: Probiotics and gut disorder. Inflammatory Bowel Diseases,7(2), 136–145. doi:10.1097/00054725-200105000-00010.
55. Eggleston, J. C., Saryan, L. A., & Hollis, D. P. (1975). Nuclear magnetic-resonance investigations of human neoplastic and abnormal non-neoplastic tissues. Cancer Research,35(5), 1326–1332.
56. Ellis, J. K., Athersuch, T. J., Thomas, L. D. K., Teichert, F., Perez-Trujillo, M., Svendsen, C., et al. (2012). Metabolic profiling detects early effects of environmental and lifestyle exposure to cadmium in a human population. BMC Medicine,10, 61. doi:10.1186/1741-7015-10-61.
57. Emwas, A. H., Al-Talla, Z. A., Guo, X., Al-Ghamdi, S., & Al-Masri, H. T. (2013a). Utilizing NMR and EPR spectroscopy to probe the role of copper in prion diseases. Magnetic Resonance in Chemistry,51(5), 255–268. doi:10.1002/mrc.3936.
58. Emwas, A.-H. M., Salek, R. M., Griffin, J. L., & Merzaban, J. (2013b). NMR-based metabolomics in human disease diagnosis: Applications, limitations, and recommendations. Metabolomics,9(5), 1048–1072. doi:10.1007/s11306-013-0524-y.
59. Emwas, A. H., Saunders, M., Ludwig, C., & Günther, U. (2008). Determinants for optimal enhancement in ex situ DNP experiments. Applied Magnetic Resonance,34(3), 483–494.
60. Enea, C., Seguin, F., Petitpas-Mulliez, J., Boildieu, N., Boisseau, N., Delpech, N., et al. (2010). H-1 NMR-based metabolomics approach for exploring urinary metabolome modifications after acute and chronic physical exercise. Analytical and Bioanalytical Chemistry,396(3), 1167–1176. doi:10.1007/s00216-009-3289-4.
61. Fabisch, W., & Fellner, C. (1957). Excretion of hippuric acid in schizophrenic and depressive patients after E.C.T. Psychosomatic Medicine,19(4), 320–325.
62. Faiz, H., Conjard-Duplany, A., Boghossian, M., Martin, G., Baverel, G., & Ferrier, B. (2011). Cadmium chloride inhibits lactate gluconeogenesis in isolated human renal proximal tubules: A cellular metabolomic approach with C-13-NMR. Archives of Toxicology,85(9), 1067–1077. doi:10.1007/s00204-010-0633-6.
63. Fanos, V., Antonucci, R., Barberini, L., & Atzori, L. (2012). Urinary metabolomics in newborns and infants. In G. S. Makowski (Ed.), Advances in Clinical Chemistry (pp. 193–223). Amsterdam: Elsevier.
64. Fanos, V., Locci, E., Noto, A., Lazzarotto, T., Manzoni, P., Atzori, L., et al. (2013). Urinary metabolomics in newborns infected by human cytomegalovirus: A preliminary investigation. Early Human Development,89(Suppl 1), S58–S61. doi:10.1016/s0378-3782(13)70017-3.
65. Farshidfar, F., Weljie, A. M., Kopciuk, K., Buie, W. D., Maclean, A., Dixon, E., et al. (2012). Serum metabolomic profile as a means to distinguish stage of colorectal cancer. Genome medicine,4(5), 42. doi:10.1186/gm341.
66. Faughnan, M. S., Hawdon, A., Ah-Singh, E., Brown, J., Millward, D. J., & Cassidy, A. (2004). Urinary isoflavone kinetics: The effect of age, gender, food matrix and chemical composition. British Journal of Nutrition,91(4), 567–574. doi:10.1079/bjn20041087.
67. Fave, G., Beckmann, M., Lloyd, A. J., Zhou, S., Harold, G., Lin, W., et al. (2011). Development and validation of a standardized protocol to monitor human dietary exposure by metabolite fingerprinting of urine samples. Metabolomics,7(4), 469–484. doi:10.1007/s11306-011-0289-0.
68. Fiehn, O., Robertson, D., Griffin, J., van der Werf, M., Nikolau, B., Morrison, N., et al. (2007). The metabolomics standards initiative (MSI). Metabolomics,3(3), 175–178. doi:10.1007/s11306-007-0070-6.
69. Foxall, P. J. D., Price, R. G., Jones, J. K., Neild, G. H., Thompson, F. D., & Nicholson, J. K. (1992). High resolution proton magnetic resonance spectroscopy of cyst fluids from patients with polycystic kidney disease. Biochimica et Biophysica Acta,1138(4), 305–314. doi:10.1016/0925-4439(92)90008-b.
70. Ganti, S., & Weiss, R. H. (2011). Urine metabolomics for kidney cancer detection and biomarker discovery. Urologic Oncology-Seminars and Original Investigations,29(5), 551–557. doi:10.1016/j.urolonc.2011.05.013.
71. Gavaghan, C. L., Holmes, E., Lenz, E., Wilson, I. D., & Nicholson, J. K. (2000). An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences: Application to the C57BL10J and Alpk: ApfCD mouse. FEBS Letters,484(3), 169–174. doi:10.1016/s0014-5793(00)02147-5.
72. Gika, H. G., Theodoridis, G. A., Wingate, J. E., & Wilson, I. D. (2007). Within-day reproducibility of an HPLC–MS-based method for metabonomic analysis: Application to human urine. Journal of Proteome Research,6(8), 3291–3303. doi:10.1021/pr070183p.
73. Godoy, M. M. G., Lopes, E. P. A., Silva, R. O., Hallwass, F., Koury, L. C. A., Moura, I. M., et al. (2010). Hepatitis C virus infection diagnosis using metabonomics. Journal of Viral Hepatitis,17(12), 854–858. doi:10.1111/j.1365-2893.2009.01252.x.
74. Gowda, G. A. N., Ijare, O. B., Shanaiah, N., & Bezabeh, T. (2009). Combining nuclear magnetic resonance spectroscopy and mass spectrometry in biomarker discovery. Biomarkers in Medicine,3(3), 307–322. doi:10.2217/bmm.09.22.
75. Griffin, J. L. (2006). The Cinderella story of metabolic profiling: Does metabolomics get to go to the functional genomics ball? Philosophical Transactions of the Royal Society B: Biological Sciences,361(1465), 147–161.
76. Grimes, J. H., & O’Connell, T. M. (2011). The application of micro-coil NMR probe technology to metabolomics of urine and serum. Journal of Biomolecular NMR,49(3–4), 297–305. doi:10.1007/s10858-011-9488-2.
77. Grison, S., Fave, G., Maillot, M., Manens, L., Delissen, O., Blanchardon, E., et al. (2013). Metabolomics identifies a biological response to chronic low-dose natural uranium contamination in urine samples. Metabolomics,9(6), 1168–1180. doi:10.1007/s11306-013-0544-7.
78. Gruetter, R., Weisdorf, S. A., Rajanayagan, V., Terpstra, M., Merkle, H., Truwit, C. L., et al. (1998). Resolution improvements in in vivo1H NMR spectra with increased magnetic field strength. Journal of Magnetic Resonance,135(1), 260–264.
79. Gu, H. W., Pan, Z. Z., Xi, B. W., Hainline, B. E., Shanaiah, N., Asiago, V., et al. (2009). H-1 NMR metabolomics study of age profiling in children. NMR in Biomedicine,22(8), 826–833. doi:10.1002/nbm.1395.
80. Guo, J., Zhang, M., Elmore, C. S., & Vishwanathan, K. (2013). An integrated strategy for in vivo metabolite profiling using high-resolution mass spectrometry based data processing techniques. Analytica Chimica Acta,780, 55–64. doi:10.1016/j.aca.2013.04.012.
81. Harris, T., Giraudeau, P., & Frydman, L. (2011). Kinetics from Indirectly detected hyperpolarized NMR spectroscopy by using spatially selective coherence transfers. Chemistry: A European Journal,17(2), 697–703.
82. Salek, Haug, K., Conesa, P., Hastings, J., Williams, M., Mahendraker, T., et al. (2013a). The MetaboLights repository: Curation challenges in metabolomics. Database: The Journal of Biological Databases and Curation. doi:10.1093/database/bat029.
83. Haug, K., Salek, R. M., Conesa, P., Hastings, J., de Matos, P., Rijnbeek, M., et al. (2013b). MetaboLights-an open-access general-purpose repository for metabolomics studies and associated meta-data. Nucleic Acids Research,41(D1), D781–D786. doi:10.1093/nar/gks1004.
84. He, C.-C., Dai, Y.-Q., Hui, R.-R., Hua, J., Chen, H.-J., Luo, Q.-Y., et al. (2012). NMR-based metabonomic approach on the toxicological effects of a Cimicifuga triterpenoid. Journal of Applied Toxicology,32(2), 88–97. doi:10.1002/jat.1633.
85. Heinzmann, S. S., Brown, I. J., Chan, Q., Bictash, M., Dumas, M.-E., Kochhar, S., et al. (2010). Metabolic profiling strategy for discovery of nutritional biomarkers: Proline betaine as a marker of citrus consumption. American Journal of Clinical Nutrition,92(2), 436–443. doi:10.3945/ajcn.2010.29672.
86. Hermjakob, H., Zhu, W., & Apweiler, R. (2003). The HUPO proteomics standards initiative. Molecular and Cellular Proteomics,2(9), 810.
87. Holmes, E., Kinross, J., Gibson, G. R., Burcelin, R., Jia, W., Pettersson, S., et al. (2012). Therapeutic modulation of microbiota-host metabolic interactions. Science Translational Medicine, 4(137). doi:10.1126/scitranslmed.3004244.
88. Holmes, E., Loo, R. L., Stamler, J., Bictash, M., Yap, I. K. S., Chan, Q., et al. (2008a). Human metabolic phenotype diversity and its association with diet and blood pressure. Nature,453(7193), 396 U350. doi:10.1038/nature06882.
89. Holmes, E., Wilson, I. D., & Nicholson, J. K. (2008b). Metabolic phenotyping in health and disease. Cell,134(5), 714–717. doi:10.1016/j.cell.2008.08.026.
90. Huang, Z., Chen, Y., Hang, W., Gao, Y., Lin, L., Li, D. Y., et al. (2013a). Holistic metabonomic profiling of urine affords potential early diagnosis for bladder and kidney cancers. Metabolomics,9(1), 119–129. doi:10.1007/s11306-012-0433-5.
91. Huang, Y., Tian, Y., Li, G., Li, Y., Yin, X., Peng, C., et al. (2013b). Discovery of safety biomarkers for realgar in rat urine using UFLC–IT–TOF/MS and H-1 NMR based metabolomics. Analytical and Bioanalytical Chemistry,405(14), 4811–4822. doi:10.1007/s00216-013-6842-0.
92. Huang, J.-H., Xie, H.-L., Yan, J., Cao, D.-S., Lu, H.-M., Xu, Q.-S., et al. (2013c). Interpretation of type 2 diabetes mellitus relevant GC-MS metabolomics fingerprints by using random forests. Analytical Methods,5(18), 4883–4889. doi:10.1039/c3ay40379c.
93. Jansen, J. J., Hoefsloot, H. C. J., van der Greef, J., Timmerman, M. E., & Smilde, A. K. (2005). Multilevel component analysis of time-resolved metabolic fingerprinting data. Analytica Chimica Acta,530(2), 173–183. doi:10.1016/j.aca.2004.09.074.
94. Jiang, L., Huang, J., Wang, Y., & Tang, H. (2012). Eliminating the dication-induced intersample chemical-shift variations for NMR-based biofluid metabonomic analysis. Analyst,137(18), 4209–4219. doi:10.1039/c2an35392j.
95. Jobu, K., Sun, C., Yoshioka, S., Yokota, J., Onogawa, M., Kawada, C., et al. (2012). Metabolomics study on the biochemical profiles of odor elements in urine of human with bladder cancer. Biological and Pharmaceutical Bulletin,35(4), 639–642.
96. Johannsen, W. J., Negrete, A., Friedman, S. H., & Feldman, E. I. (1962). A re-examination of the hippuric acid–anxiety relationship. Psychosomatic Medicine,24(6), 569.
97. Jung, J. Y., Lee, H.-S., Kang, D.-G., Kim, N. S., Cha, M. H., Bang, O.-S., et al. (2011). H-1-NMR-based metabolomics study of cerebral infarction. Stroke,42(5), 1282–1288. doi:10.1161/strokeaha.110.598789.
98. Kang, S.-M., Park, J.-C., Shin, M.-J., Lee, H., Oh, J., Ryu, D. H., et al. (2011). H-1 nuclear magnetic resonance based metabolic urinary profiling of patients with ischemic heart failure. Clinical Biochemistry,44(4), 293–299. doi:10.1016/j.clinbiochem.2010.11.010.
99. Karamani, A. A., Fiamegos, Y. C., Vartholomatos, G., & Stalikas, C. D. (2013). Fluoroacetylation/fluoroethylesterification as a derivatization approach for gas chromatography-mass spectrometry in metabolomics: Preliminary study of lymphohyperplastic diseases. Journal of Chromatography A,1302, 125–132. doi:10.1016/j.chroma.2013.05.080.
100. Kell, D. B. (2006). Systems biology, metabolic modelling and metabolomics in drug discovery and development. Drug Discovery Today,11(23–24), 1085–1092.
101. Keun, H. C., Beckonert, O., Griffin, J. L., Richter, C., Moskau, D., Lindon, J. C., et al. (2002). Cryogenic probe 13C NMR spectroscopy of urine for metabonomic studies. Analytical Chemistry,74(17), 4588–4593.
102. Kim, J. W., Ryu, S. H., Kim, S., Lee, H. W., Lim, M.-S., Seong, S. J., et al. (2013). Pattern recognition analysis for hepatotoxicity induced by acetaminophen using plasma and urinary H-1 NMR-based metabolomics in humans. Analytical Chemistry,85(23), 11326–11334. doi:10.1021/ac402390q.
103. Kim, K., Taylor, S. L., Ganti, S., Guo, L., Osier, M. V., & Weiss, R. H. (2011). Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer. OMICS: A Journal of Integrative Biology,15(5), 293–303. doi:10.1089/omi.2010.0094.
104. Kochhar, S., Jacobs, D. M., Ramadan, Z., Berruex, F., Fuerhoz, A., & Fay, L. B. (2006). Probing gender-specific metabolism differences in humans by nuclear magnetic resonance-based metabonomics. Analytical Biochemistry,352(2), 274–281. doi:10.1016/j.ab.2006.02.033.
105. Kotlowska, A., Sworczak, K., & Stepnowski, P. (2011). Urine metabolomics analysis for adrenal incidentaloma activity detection and biomarker discovery. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences,879(5–6), 359–363. doi:10.1016/j.jchromb.2010.12.021.
106. Krojanski, H. G., Lambert, J., Gerikalan, Y., Suter, D., & Hergenroeder, R. (2008). Microslot NMR probe for metabolomics studies. Analytical Chemistry,80(22), 8668–8672. doi:10.1021/ac801636a.
107. Kuhara, T., Ohse, M., Inoue, Y., & Cooper, A. J. L. (2011). A GC/MS-based metabolomic approach for diagnosing citrin deficiency. Analytical and Bioanalytical Chemistry,400(7), 1881–1894. doi:10.1007/s00216-011-4766-0.
108. Kumar, V., Dwivedi, D. K., & Jagannathan, N. R. (2014). High-resolution NMR spectroscopy of human body fluids and tissues in relation to prostate cancer. NMR in Biomedicine,27(1), 80–89. doi:10.1002/nbm.2979.
109. Kumar, A., Ernst, R. R., & Wuthrich, K. (1980). A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. Biochemical and Biophysical Research Communications,95(1), 1–6. doi:10.1016/0006-291x(80)90695-6.
110. Kumar, B. S., Lee, Y.-J., Yi, H. J., Chung, B. C., & Jung, B. H. (2010). Discovery of safety biomarkers for atorvastatin in rat urine using mass spectrometry based metabolomics combined with global and targeted approach. Analytica Chimica Acta,661(1), 47–59. doi:10.1016/j.aca.2009.11.063.
111. Lan, K., Zhang, Y., Yang, J., & Xu, L. (2010). Simple quality assessment approach for herbal extracts using high performance liquid chromatography–UV based metabolomics platform. Journal of Chromatography A,1217(8), 1414–1418. doi:10.1016/j.chroma.2009.12.031.
112. Lauridsen, M., Hansen, S. H., Jaroszewski, J. W., & Cornett, C. (2007). Human urine as test material in H-1 NMR-based metabonomics: Recommendations for sample preparation and storage. Analytical Chemistry,79(3), 1181–1186. doi:10.1021/ac061354x.
113. Lee, S. H., An, J. H., Park, H.-M., & Jung, B. H. (2012). Investigation of endogenous metabolic changes in the urine of pseudo germ-free rats using a metabolomic approach. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences,887, 8–18. doi:10.1016/j.jchromb.2011.12.030.
114. Lees, H. J., Swann, J. R., Wilson, I. D., Nicholson, J. K., & Holmes, E. (2013). Hippurate: The natural history of a mammalian-microbial cometabolite. Journal of Proteome Research,12(4), 1527–1546. doi:10.1021/pr300900b.
115. Lenz, E. M., Bright, J., Wilson, I. D., Hughes, A., Morrisson, J., Lindberg, H., et al. (2004). Metabonomics, dietary influences and cultural differences: A H-1 NMR-based study of urine samples obtained from healthy British and Swedish subjects. Journal of Pharmaceutical and Biomedical Analysis,36(4), 841–849. doi:10.1016/j.jpba.2004.08.002.
116. Lewis, D. A., Brown, R., Williams, J., White, P., Jacobson, S. K., Marchesi, J. R., et al. (2013). The human urinary microbiome: Bacterial DNA in voided urine of asymptomatic adults. Frontiers in Cellular and Infection Microbiology, 3. doi:10.3389/fcimb.2013.00041.
117. Li, J., Wang, S., Wang, M., Shi, W., Du, X., & Sun, C. (2013). The toxicity of 3-chloropropane-1,2-dipalmitate in Wistar rats and a metabonomics analysis of rat urine by ultra-performance liquid chromatography–mass spectrometry. Chemico-Biological Interactions,206(2), 337–345. doi:10.1016/j.cbi.2013.10.004.
118. Liang, X., Zhang, L., Zhang, X., Dai, W., Li, H., Hu, L., et al. (2010). Qualitative and quantitative analysis of traditional Chinese medicine Niu Huang Jie Du Pill using ultra performance liquid chromatography coupled with tunable UV detector and rapid resolution liquid chromatography coupled with time-of-flight tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis,51(3), 565–571. doi:10.1016/j.jpba.2009.09.015.
119. Liu, Y., Huang, R., Liu, L., Peng, J., Xiao, B., Yang, J., et al. (2010). Metabonomics study of urine from Sprague-Dawley rats exposed to Huang-yao-zi using H-1 NMR spectroscopy. Journal of Pharmaceutical and Biomedical Analysis,52(1), 136–141. doi:10.1016/j.jpba.2009.12.026.
120. Llorach, R., Urpi-Sarda, M., Jauregui, O., Monagas, M., & Andres-Lacueva, C. (2009). An LC–MS-based metabolomics approach for exploring urinary metabolome modifications after cocoa consumption. Journal of Proteome Research,8(11), 5060–5068. doi:10.1021/pr900470a.
121. Llorach-Asuncion, R., Jauregui, O., Urpi-Sarda, M., & Andres-Lacueva, C. (2010). Methodological aspects for metabolome visualization and characterization A metabolomic evaluation of the 24 h evolution of human urine after cocoa powder consumption. Journal of Pharmaceutical and Biomedical Analysis,51(2), 373–381. doi:10.1016/j.jpba.2009.06.033.
122. Lloyd, A. J., Beckmann, M., Fave, G., Mathers, J. C., & Draper, J. (2011). Proline betaine and its biotransformation products in fasting urine samples are potential biomarkers of habitual citrus fruit consumption. British Journal of Nutrition,106(6), 812–824. doi:10.1017/s0007114511001164.
123. Lodi, A., Tiziani, S., Khanim, F. L., Guenther, U. L., Viant, M. R., Morgan, G. J., et al. (2013). Proton NMR-based metabolite analyses of archived serial paired serum and urine samples from myeloma patients at different stages of disease activity identifies acetylcarnitine as a novel marker of active disease. PloS One, 8(2). doi:10.1371/journal.pone.0056422.
124. Lu, Y., Yao, D., & Chen, C. (2013). 2-Hydrazinoquinoline as a novel derivatization agent for LC–MS-based metabolomic investigation of streptozotocin-elicited ketoacidosis. Faseb Journal, 27.
125. Ludwig, C., Marin-Montesinos, I., Saunders, M. G., Emwas, A. H., Pikramenou, Z., Hammond, S. P., et al. (2010). Application of ex situ dynamic nuclear polarization in studying small molecules. Physical Chemistry Chemical Physics: PCCP,12(22), 5868–5871.
126. Maher, A. D., Lindon, J. C., & Nicholson, J. K. (2009). H-1 NMR-based metabonomics for investigating diabetes. Future Medicinal Chemistry,1(4), 737–747. doi:10.4155/fmc.09.54.
127. Martin Hernandez, E., Aparicio Lopez, C., Alvarez Calatayud, G., & Garcia Herrera, M. A. (2001). Vesical uric acid lithiasis in a child with renal hypouricemia. Anales Espanoles de Pediatria,55(3), 273–276.
128. Martin, F.-P. J., Verdu, E. F., Wang, Y., Dumas, M.-E., Yap, I. K. S., Cloarec, O., et al. (2006). Transgenomic metabolic interactions in a mouse disease model: Interactions of Trichinella spiralis infection with dietary Lactobacillus paracasei supplementation. Journal of Proteome Research,5(9), 2185–2193. doi:10.1021/pr060157b.
129. Mattar, S. M., Emwas, A. H., & Calhoun, L. A. (2004). Spectroscopic studies of the intermediates in the conversion of 1,4,11,12-tetrahydro-9,10-anthraquinone to 9,10-anthraquinone by reaction with oxygen under basic conditions. Journal of Physical Chemistry A,108(52), 11545–11553. doi:10.1021/jp040280v.
130. Mavel, S., Nadal-Desbarats, L., Blasco, H., Bonnet-Brilhault, F., Barthelemy, C., Montigny, F., et al. (2013). H-1-C-13 NMR-based urine metabolic profiling in autism spectrum disorders. Talanta,114, 95–102. doi:10.1016/j.talanta.2013.03.064.
131. McKee, C. L. G., Wilson, I. D., & Nicholson, J. K. (2006). Metabolic phenotyping of nude and normal (Alpk: ApfCD, C57BL10J) mice. Journal of Proteome Research,5(2), 378–384. doi:10.1021/pr050255h.
132. Mehrpour, M., Kyani, A., Tafazzoli, M., Fathi, F., & Joghataie, M.-T. (2013). A metabonomics investigation of multiple sclerosis by nuclear magnetic resonance. Magnetic Resonance in Chemistry: MRC,51(2), 102–109. doi:10.1002/mrc.3915.
133. Michell, A. W., Mosedale, D., Grainger, D. J., & Barker, R. A. (2008). Metabolomic analysis of urine and serum in Parkinson’s disease. Metabolomics,4(3), 191–201. doi:10.1007/s11306-008-0111-9.
134. Monteiro, M. S., Carvalho, M., Bastos, M. L., & Guedes de Pinho, P. (2013). Metabolomics analysis for biomarker discovery: Advances and challenges. Current Medicinal Chemistry,20(2), 257–271.
135. Nageeb, A., Al-Tawashi, A., Emwas, A.-H. M., Al-Talla, Z. A. H., & Al-Rifai, N. (2013). Comparison of artemisia annua bioactivities between traditional medicine and chemical extracts. Current Bioactive Compounds,9(4), 324.
136. Nahon, P., Amathieu, R., Triba, M. N., Bouchemal, N., Nault, J.-C., Ziol, M., et al. (2012). Identification of serum proton NMR metabolomic fingerprints associated with hepatocellular carcinoma in patients with alcoholic cirrhosis. Clinical Cancer Research,18(24), 6714–6722. doi:10.1158/1078-0432.ccr-12-1099.
137. Nambiar, P. R., Gupta, R. R., & Misra, V. (2010). An “Omics” based survey of human colon cancer. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis,693(1–2), 3–18.
138. Nevedomskaya, E., Pacchiarotta, T., Artemov, A., Meissner, A., van Nieuwkoop, C., van Dissel, J. T., et al. (2012). H-1 NMR-based metabolic profiling of urinary tract infection: Combining multiple statistical models and clinical data. Metabolomics,8(6), 1227–1235. doi:10.1007/s11306-012-0411-y.
139. Nicholls, A. W., Mortishire-Smith, R. J., & Nicholson, J. K. (2003). NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. Chemical Research in Toxicology,16(11), 1395–1404. doi:10.1021/tx0340293.
140. Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., et al. (2012). Host-gut microbiota metabolic interactions. Science,336(6086), 1262–1267. doi:10.1126/science.1223813.
141. Nicholson, J. K., Holmes, E., & Wilson, I. D. (2005). Gut microorganisms, mammalian metabolism and personalized health care. Nature Reviews Microbiology,3(5), 431–438. doi:10.1038/nrmicro1152.
142. Nicholson, J. K., & Wilson, I. D. (2003). Understanding ‘global’ systems biology: Metabonomics and the continuum of metabolism. Nature Reviews Drug Discovery,2(8), 668–676. doi:10.1038/nrd1157.
143. Nie, C. Y., Han, T., Zhang, L., Li, Y., Liu, H., Xiao, S. X., et al. (2014). Cross-sectional and dynamic change of serum metabolite profiling for hepatitis B-related acute-on-chronic liver failure by UPLC/MS. Journal of Viral Hepatitis,21(1), 53–63. doi:10.1111/jvh.12122.
144. Norskov, N. P., Hedemann, M. S., Laerke, H. N., & Knudsen, K. E. B. (2013). Multicompartmental nontargeted LC–MS metabolomics: Explorative study on the metabolic responses of rye fiber versus refined wheat fiber intake in plasma and urine of hypercholesterolemic pigs. Journal of Proteome Research,12(6), 2818–2832. doi:10.1021/pr400164b.
145. O’Connell, T. M. (2012). Recent advances in metabolomics in oncology. Bioanalysis,4(4), 431–451. doi:10.4155/bio.11.326.
146. Orchard, S., Hermjakob, H., & Apweiler, R. (2003). The proteomics standards initiative. Proteomics,3(7), 1374–1376. doi:10.1002/pmic.200300496.
147. O’Sullivan, A., Gibney, M. J., & Brennan, L. (2011). Dietary intake patterns are reflected in metabolomic profiles: Potential role in dietary assessment studies. American Journal of Clinical Nutrition,93(2), 314–321. doi:10.3945/ajcn.110.000950.
148. Pechlivanis, A., Kostidis, S., Saraslanidis, P., Petridou, A., Tsalis, G., Mougios, V., et al. (2010). H-1 NMR-based metabonomic investigation of the effect of two different exercise sessions on the metabolic fingerprint of human urine. Journal of Proteome Research,9(12), 6405–6416. doi:10.1021/pr100684t.
149. Pereira, D. I. A., & Gibson, G. R. (2002). Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Critical Reviews in Biochemistry and Molecular Biology,37(4), 259–281. doi:10.1080/10409230290771519.
150. Persky, H., Grinker, R. R., & Mirsky, I. A. (1950). The excretion of hippuric acid in subjects with free anxiety. Journal of Clinical Investigation,29(1), 110–114. doi:10.1172/jci102226.
151. Potts, B. C. M., Deese, A. J., Stevens, G. J., Reily, M. D., Robertson, D. G., & Theiss, J. (2001). NMR of biofluids and pattern recognition: Assessing the impact of NMR parameters on the principal component analysis of urine from rat and mouse. Journal of Pharmaceutical and Biomedical Analysis,26(3), 463–476. doi:10.1016/s0731-7085(01)00430-7.
152. Psihogios, N. G., Gazi, I. F., Elisaf, M. S., Seferiadis, K. I., & Bairaktari, E. T. (2008). Gender-related and age-related urinalysis of healthy subjects by NMR-based metabonomics. NMR in Biomedicine,21(3), 195–207. doi:10.1002/nbm.1176.
153. Psychogios, N., Hau, D. D., Peng, J., Guo, A. C., Mandal, R., Bouatra, S., et al. (2011). The human serum metabolome. PLoS ONE,6(2), e16957.
154. Pu, S., Chen, J., Wang, J.-B., Zhang, P., Zou, Z.-S., Sun, Y., et al. (2012). A new 1H NMR-based metabolomics approach for the diagnosis of autoimmune hepatitis. Hepatology,56, 719A–720A.
155. Qiu, Y., Cai, G., Su, M., Chen, T., Liu, Y., Xu, Y., et al. (2010). Urinary metabonomic study on colorectal cancer. Journal of Proteome Research,9(3), 1627–1634. doi:10.1021/pr901081y.
156. Quastel, J. H., & Wales, W. T. (1938). Faulty detoxication in schizophrenia—abnormal excretion of hippuric acid after aiministration of benzoate. Lancet,2, 301–305.
157. Raamsdonk, L. M., Teusink, B., Broadhurst, D., Zhang, N., Hayes, A., Walsh, M. C., et al. (2001). A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nature Biotechnology,19(1), 45–50.
158. Rai, R. K., & Sinha, N. (2012). Fast and accurate quantitative metabolic profiling of body fluids by nonlinear sampling of H-1-C-13 two-dimensional nuclear magnetic resonance spectroscopy. Analytical Chemistry,84(22), 10005–10011. doi:10.1021/ac302457s.
159. Rantalainen, M., Cloarec, O., Beckonert, O., Wilson, I., Jackson, D., Tonge, R., et al. (2006). Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice. Journal of Proteome Research,5(10), 2642–2655.
160. Rasmussen, L. G., Savorani, F., Larsen, T. M., Dragsted, L. O., Astrup, A., & Engelsen, S. B. (2011). Standardization of factors that influence human urine metabolomics. Metabolomics,7(1), 71–83.
161. Rasmussen, L. G., Winning, H., Savorani, F., Toft, H., Larsen, T. M., Dragsted, L. O., et al. (2012). Assessment of the effect of high or low protein diet on the human urine metabolome as measured by NMR. Nutrients,4(2), 112–131. doi:10.3390/nu4020112.
162. Ravel, J., Gajer, P., Abdo, Z., Schneider, G. M., Koenig, S. S. K., McCulle, S. L., et al. (2011). Vaginal microbiome of reproductive-age women. Proceedings of the National Academy of Sciences of the United States of America,108, 4680–4687. doi:10.1073/pnas.1002611107.
163. Rist, M. J., Muhle-Goll, C., Görling, B., Bub, A., Heissler, S., Watzl, B., et al. (2013). Influence of freezing and storage procedure on human urine samples in NMR-based Metabolomics. Metabolites,3, 243–258.
164. Rocca-Serra, P., Brandizi, M., Maguire, E., Sklyar, N., Taylor, C., Begley, K., et al. (2010). ISA software suite: Supporting standards-compliant experimental annotation and enabling curation at the community level. Bioinformatics,26(18), 2354–2356. doi:10.1093/bioinformatics/btq415.
165. Ryan, D., Robards, K., Prenzler, P., & Kendall, M. (2011). Recent and potential developments in the analysis of urine: A review. Analytica Chimica Acta,684(1), 17–29.
166. Rylander, R., Remer, T., Berkemeyer, S., & Vormann, J. (2006). Acid–base status affects renal magnesium losses in healthy, elderly persons. Journal of Nutrition,136(9), 2374–2377.
167. Sachse, D., Sletner, L., Morkrid, K., Jenum, A. K., Birkeland, K., Rise, F., et al. (2012). Metabolic changes in urine during and after pregnancy in a large, multiethnic population-based cohort study of gestational diabetes. PloS One, 7(12). doi:e5239910.1371/journal.pone.0052399.
168. Salek, R. M., Haug, K., & Steinbeck, C. (2013a). Dissemination of metabolomics results: Role of metaboLights and COSMOS. GigaScience,2(1), 8. doi:10.1186/2047-217x-2-8.
169. Salek, R. M., Maguire, M. L., Bentley, E., Rubtsov, D. V., Hough, T., Cheeseman, M., et al. (2007). A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiological Genomics,29(2), 99–108. doi:10.1152/physiolgenomics.00194.2006.
170. Salek, R. M., Steinbeck, C., Viant, M. R., Goodacre, R., & Dunn, W. B. (2013b). The role of reporting standards for metabolite annotation and identification in metabolomic studies. GigaScience,2(1), 13. doi:10.1186/2047-217x-2-13.
171. Saude, E. J., Adamko, D., Rowe, B. H., Marrie, T., & Sykes, B. D. (2007). Variation of metabolites in normal human urine. Metabolomics,3(4), 439–451. doi:10.1007/s11306-007-0091-1.
172. Saude, E. J., & Sykes, B. D. (2007). Urine stability for metabolomic studies: effects of preparation and storage. Metabolomics,3(1), 19–27. doi:10.1007/s11306-006-0042-2.
173. Schicho, R., Shaykhutdinov, R., Ngo, J., Nazyrova, A., Schneider, C., Panaccione, R., et al. (2012). Quantitative metabolomic profiling of serum, plasma, and urine by H-1 NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals. Journal of Proteome Research,11(6), 3344–3357. doi:10.1021/pr300139q.
174. Sengupta, A., Ghosh, S., Basant, A., Malusare, S., Johri, P., Pathak, S., et al. (2011). Global host metabolic response to Plasmodium vivax infection: A H-1 NMR based urinary metabonomic study. Malaria Journal, 10. doi: 384/1475-2875-10-384.
175. Serkova, N. J., Freund, A. S., Brown, J. L., & Kominsky, D. J. (2009). Use of the 1-mm micro-probe for metabolic analysis on small volume biological samples. Journal of Cellular and Molecular Medicine,13(8B), 1933–1941. doi:10.1111/j.1582-4934.2008.00464.x.
176. Shah, A., Bhandary, S., Malik, S. L., Risal, P., & Koju, R. (2009). Waist circumference and waist-hip ratio as predictors of type 2 diabetes mellitus in the Nepalese population of Kavre District. Nepal Medical College Journal: NMCJ,11(4), 261–267.
177. Siqueira, M., & Paiva, M. J. N. (2002). Hippuric acid in urine: Reference values. Revista de Saude Publica,36(6), 723–727. doi:10.1590/s0034-89102002000700010.
178. Slupsky, C. M., Rankin, K. N., Wagner, J., Fu, H., Chang, D., Weljie, A. M., et al. (2007). Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Analytical Chemistry,79(18), 6995–7004. doi:10.1021/ac0708588.
179. Stella, C., Beckwith-Hall, B., Cloarec, O., Holmes, E., Lindon, J. C., Powell, J., et al. (2006). Susceptibility of human metabolic phenotypes to dietary modulation. Journal of Proteome Research,5(10), 2780–2788. doi:10.1021/pr060265y.
180. Sukumaran, D. K., Garcia, E., Hua, J., Tabaczynski, W., Odunsi, K., Andrews, C., et al. (2009). Standard operating procedure for metabonomics studies of blood serum and plasma samples using a H-1-NMR micro-flow probe. Magnetic Resonance in Chemistry,47, S81–S85. doi:10.1002/mrc.2469.
181. Sumner, L. W., Amberg, A., Barrett, D., Beale, M. H., Beger, R., Daykin, C. A., et al. (2007). Proposed minimum reporting standards for chemical analysis. Metabolomics,3(3), 211–221. doi:10.1007/s11306-007-0082-2.
182. Sun, B., Li, L., Wu, S., Zhang, Q., Li, H., Chen, H., et al. (2009). Metabolomic analysis of biofluids from rats treated with aconitum alkaloids using nuclear magnetic resonance and gas chromatography/time-of-flight mass spectrometry. Analytical Biochemistry,395(2), 125–133. doi:10.1016/j.ab.2009.08.014.
183. Szultka, M., Krzeminski, R., Walczak, J., Jackowski, M., & Buszewski, B. (2014). Pharmacokinetic study of amoxicillin in human plasma by solid-phase microextraction followed by high-performance liquid chromatography-triple quadrupole mass spectrometry. Biomedical Chromatography,28(2), 255–264.
184. Tang, J., Tan, C. Y., Oresic, M., & Vidal-Puig, A. (2009). Integrating post-genomic approaches as a strategy to advance our understanding of health and disease. Genome Med,1(3), e35.
185. Thomas, C. E., Sexton, W., Benson, K., Sutphen, R., & Koomen, J. (2010). Urine collection and processing for protein biomarker discovery and quantification. Cancer Epidemiology, Biomarkers and Prevention,19(4), 953–959. doi:10.1158/1055-9965.epi-10-0069.
186. Thongboonkerd, V., Chutipongtanate, S., & Kanlaya, R. (2006). Systematic evaluation of sample preparation methods for gel-based human urinary proteomics: Quantity, quality, and variability. Journal of Proteome Research,5(1), 183–191. doi:10.1021/pr0502525.
187. Tjellstroem, B., Stenhammar, L., Hoegberg, L., Faelth-Magnusson, K., Magnusson, K.-E., Midtvedt, T., et al. (2007). Gut microflora associated characteristics in first-degree relatives of children with celiac disease. Scandinavian Journal of Gastroenterology,42(10), 1204–1208. doi:10.1080/00365520701320687.
188. Torrazza, R. M., & Neu, J. (2011). The developing intestinal microbiome and its relationship to health and disease in the neonate. Journal of Perinatology,31, S29–S34. doi:10.1038/jp.2010.172.
189. Tsutsui, H., Maeda, T., Toyo’oka, T., Min, J. Z., Inagaki, S., Higashi, T., et al. (2010). Practical analytical approach for the identification of biomarker candidates in prediabetic state based upon metabonomic study by ultraperformance liquid chromatography coupled to electrospray ionization time-of-flight mass spectrometry. Journal of Proteome Research,9(8), 3912–3922. doi:10.1021/pr100121k.
190. Tzovaras, V. T., Psychogios, N. G., Kostara, C. E., Bairaktari, E. T., & Elisaf, M. S. (2009). Evaluation of the proximal tubular function in individuals with primary renal hypouricemia: An NMR-based metabonomic study. NMR in Biomedicine,22(10), 1072–1083. doi:10.1002/nbm.1415.
191. Urbanczyk-Wochniak, E., Luedemann, A., Kopka, J., Selbig, J., Roessner-Tunali, U., Willmitzer, L., et al. (2003). Parallel analysis of transcript and metabolic profiles: A new approach in systems biology. EMBO Reports,4(10), 989–993.
192. Vadla, N. C., Davalagar, V. D., & Sripadi, P. (2013). Detection and characterization of N-alkyl diethanolamines and N-2-alkoxyethyl diethanolamines in milk by electrospray ionization mass spectrometry. Metabolomics,9(3), 623–630. doi:10.1007/s11306-012-0492-7.
193. van der Kloet, F. M., Tempels, F. W. A., Ismail, N., van der Heijden, R., Kasper, P. T., Rojas-Cherto, M., et al. (2012). Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study). Metabolomics,8(1), 109–119. doi:10.1007/s11306-011-0291-6.
194. van Doorn, M., Vogels, J., Tas, A., van Hoogdalem, E. J., Burggraaf, J., Cohen, A., et al. (2007). Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers. British Journal of Clinical Pharmacology,63(5), 562–574. doi:10.1111/j.1365-2125.2006.02816.x.
195. Vestergren, J., Vincent, A. G., Jansson, M., Persson, P., Istedt, U., Groebner, G., et al. (2012). High-resolution characterization of organic phosphorus in soil extracts using 2D H-1-P-31 NMR correlation spectroscopy. Environmental Science and Technology,46(7), 3950–3956. doi:10.1021/es204016h.
196. Walsh, M. C., Brennan, L., Malthouse, J. P. G., Roche, H. M., & Gibney, M. J. (2006). Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. American Journal of Clinical Nutrition,84(3), 531–539.
197. Walsh, M. C., Brennan, L., Pujos-Guillot, E., Sebedio, J.-L., Scalbert, A., Fagan, A., et al. (2007). Influence of acute phytochemical intake on human urinary metabolomic profiles. American Journal of Clinical Nutrition,86(6), 1687–1693.
198. Wang, B., Goodpaster, A. M., & Kennedy, M. A. (2013a). Coefficient of variation, signal-to-noise ratio, and effects of normalization in validation of biomarkers from NMR-based metabonomics studies. Chemometrics and Intelligent Laboratory Systems,128, 9–16. doi:10.1016/j.chemolab.2013.07.007.
199. Wang, L., Tang, Y., Liu, S., Mao, S., Ling, Y., Liu, D., et al. (2013). Metabonomic profiling of serum and urine by H-1 NMR-based spectroscopy discriminates patients with chronic obstructive pulmonary disease and healthy individuals. PloS One, 8(6). doi: 10.1371/journal.pone.0065675.
200. Wang, H., Tso, V. K., Slupsky, C. M., & Fedorak, R. N. (2010). Metabolomics and detection of colorectal cancer in humans: A systematic review. Future Oncology,6(9), 1395–1406. doi:10.2217/fon.10.107.
201. Weiss, R. H., & Kim, K. (2012). Metabolomics in the study of kidney diseases. Nature Reviews Nephrology,8(1), 22–33. doi:10.1038/nrneph.2011.152.
202. Welch, A. A., Mulligan, A., Bingham, S. A., & Khaw, K.-T. (2008). Urine pH is an indicator of dietary acid-base load, fruit and vegetables and meat intakes: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk population study. British Journal of Nutrition,99(6), 1335–1343. doi:10.1017/s0007114507862350.
203. Wen, H., Yoo, S. S., Kang, J., Kim, H. G., Park, J.-S., Jeong, S., et al. (2010). A new NMR-based metabolomics approach for the diagnosis of biliary tract cancer. Journal of Hepatology,52(2), 228–233.
204. Westerhuis, J. A., van Velzen, E. J. J., Hoefsloot, H. C. J., & Smilde, A. K. (2010). Multivariate paired data analysis: Multilevel PLSDA versus OPLSDA. Metabolomics,6(1), 119–128. doi:10.1007/s11306-009-0185-z.
205. Weusten, J. J. A. M., Derks, E. P. P. A., Momrners, J. H. M., & van der Wal, S. (2012). Alignment and clustering strategies for GC × GC–MS features using a cylindrical mapping. Analytica Chimica Acta,726, 9–21. doi:10.1016/j.aca.2012.03.009.
206. Williams, R. E., Eyton-Jones, H. W., Farnworth, M. J., Gallagher, R., & Provan, W. M. (2002). Effect of intestinal microflora on the urinary metabolic profile of rats: A H-1-nuclear magnetic resonance spectroscopy study. Xenobiotica,32(9), 783–794. doi:10.1080/00498250210143047.
207. Winnike, J. H., Busby, M. G., Watkins, P. B., & O’Connell, T. M. (2009). Effects of a prolonged standardized diet on normalizing the human metabolome. American Journal of Clinical Nutrition,90(6), 1496–1501. doi:10.3945/ajcn.2009.28234.
208. Wishart, D. S. (2008). Quantitative metabolomics using NMR. Trac-Trends in Analytical Chemistry,27(3), 228–237. doi:10.1016/j.trac.2007.12.001.
209. Wishart, D. S., Knox, C., Guo, A. C., Eisner, R., Young, N., Gautam, B., et al. (2009). HMDB: A knowledgebase for the human metabolome. Nucleic Acids Research,37, D603–D610. doi:10.1093/nar/gkn810.
210. Wishart, D. S., Tzur, D., Knox, C., Eisner, R., Guo, A. C., Young, N., et al. (2007). HMDB: The human metabolome database. Nucleic Acids Research,35, D521–D526. doi:10.1093/nar/gkl923.
211. Xiao, C., Hao, F., Qin, X., Wang, Y., & Tang, H. (2009). An optimized buffer system for NMR-based urinary metabonomics with effective pH control, chemical shift consistency and dilution minimization. Analyst,134(5), 916–925. doi:10.1039/b818802e.
212. Xie, G. X., Chen, T. L., Qiu, Y. P., Shi, P., Zheng, X. J., Su, M. M., et al. (2012). Urine metabolite profiling offers potential early diagnosis of oral cancer. Metabolomics,8(2), 220–231. doi:10.1007/s11306-011-0302-7.
213. Yap, I. K. S., Angley, M., Veselkov, K. A., Holmes, E., Lindon, J. C., & Nicholson, J. K. (2010). Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. Journal of Proteome Research,9(6), 2996–3004. doi:10.1021/pr901188e.
214. Yizhak, K., Benyamini, T., Liebermeister, W., Ruppin, E., & Shlomi, T. (2010). Integrating quantitative proteomics and metabolomics with a genome-scale metabolic network model. Bioinformatics,26(12), i255–i260.
215. Zacharias, H. U., Schley, G., Hochrein, J., Klein, M. S., Koeberle, C., Eckardt, K.-U., et al. (2013). Analysis of human urine reveals metabolic changes related to the development of acute kidney injury following cardiac surgery. Metabolomics,9(3), 697–707. doi:10.1007/s11306-012-0479-4.
216. Zhang, S., Gowda, G. A. N., Asiago, V., Shanaiah, N., Barbas, C., & Raftery, D. (2008). Correlative and quantitative H-1 NMR-based metabolomics reveals specific metabolic pathway disturbances in diabetic rats. Analytical Biochemistry,383(1), 76–84. doi:10.1016/j.ab.2008.07.041.
217. Zhang, S., Gowda, G. A. N., Ye, T., & Raftery, D. (2010). Advances in NMR-based biofluid analysis and metabolite profiling. Analyst,135(7), 1490–1498. doi:10.1039/c000091d.
218. Zhang, J., Wei, S., Liu, L., Gowda, G. A. N., Bonney, P., Stewart, J., et al. (2012). NMR-based metabolomics study of canine bladder cancer. Biochimica Et Biophysica Acta-Molecular Basis of Disease,1822(11), 1807–1814. doi:10.1016/j.bbadis.2012.08.001.
219. Zhang, X., Xu, L., Shen, J., Cao, B., Cheng, T., Zhao, T., et al. (2013). Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum. Biochimica Et Biophysica Acta-Molecular Basis of Disease,1832(8), 1207–1216. doi:10.1016/j.bbadis.2013.03.009.
220. Zheng, P., Chen, J.-J., Huang, T., Wang, M.-J., Wang, Y., Dong, M.-X., et al. (2013). A novel urinary metabolite signature for diagnosing major depressive disorder. Journal of Proteome Research,12(12), 5904–5911. doi:10.1021/pr400939q.
221. Zheng, S., Yu, M., Lu, X., Huo, T., Ge, L., Yang, J., et al. (2010). Urinary metabonomic study on biochemical changes in chronic unpredictable mild stress model of depression. Clinica Chimica Acta,411(3–4), 204–209. doi:10.1016/j.cca.2009.11.003.
222. Zuppi, C., Messana, I., Tapanainen, P., Knip, M., Vincenzoni, F., Giardina, B., et al. (2002). Proton nuclear magnetic resonance spectral profiles of urine from children and adolescents with type 1 diabetes. Clinical Chemistry,48(4), 660–662.